UB
CTKB icon

UMB Bank’s Cytek Biosciences CTKB Stock Holding History

UMB Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Sell
833
-572
-41% -$2.44K ﹤0.01% 2134
2026
Q1 		$6.14K Buy
1,405
+23
+2% +$109 ﹤0.01% 1994
2025
Q4 		$6.98K Buy
1,382
+451
+48% +$2.09K ﹤0.01% 1937
2025
Q3 		$3.23K Buy
931
+67
+8% +$252 ﹤0.01% 1975
2025
Q2 		$2.94K Buy
864
+814
+1,628% +$2.71K ﹤0.01% 1946
2025
Q1 		$201 Sell
50
-323
-87% -$1.67K ﹤0.01% 2082
2024
Q4 		$2.42K Buy
373
+242
+185% +$1.44K ﹤0.01% 1898
2024
Q3 		$726 Buy
131
+81
+162% +$459 ﹤0.01% 2086
2024
Q2 		$279 Sell
50
-2
-4% -$12 ﹤0.01% 2108
2024
Q1 		$349 Buy
+52
New +$411 ﹤0.01% 2058

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UMB Bank's CTKB Position: Q2 2026 in Review

UMB Bank reduced its Cytek Biosciences (CTKB) stake by 41% in Q2 2026, selling an estimated $2.44K and leaving 833 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

UMB Bank first reported a position in CTKB in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.98K in Q4 2025. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • UMB Bank held 833 shares of Cytek Biosciences worth $3.69K as of Q2 2026.
  • UMB Bank sold 572 Cytek Biosciences shares in Q2 2026, an estimated $2.44K.
  • Cytek Biosciences made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2134 holding.
  • UMB Bank first reported a position in Cytek Biosciences in Q1 2024 and has held it in 10 quarters since.
  • UMB Bank's Cytek Biosciences position peaked at $6.98K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.